Corvus Pharmaceuticals, Inc. - Common Stock (CRVS)

111 filings reported holding CRVS - Corvus Pharmaceuticals, Inc. - Common Stock as of Q4 2024.
Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,723,156 shares of 74,361,296 outstanding shares and own 51% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6,943,654 shares), SAMLYN CAPITAL, LLC (6,667,105 shares), ADAMS STREET PARTNERS LLC (3,275,616 shares), Point72 Asset Management, L.P. (3,030,011 shares), RTW INVESTMENTS, LP (2,679,479 shares), VANGUARD GROUP INC (2,454,596 shares), Vivo Capital, LLC (2,234,566 shares), Foresite Capital Management VI LLC (1,581,233 shares), BlackRock, Inc. (1,072,941 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (1,015,083 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.